LIMITATION OF MYOCARDIAL INFARCT SIZE IN PIGS WITH A DUAL LIPOXYGENASE-CYCLOOXYGENASE BLOCKING-AGENT BY INHIBITION OF NEUTROPHIL ACTIVITY WITHOUT REDUCTION OF NEUTROPHIL MIGRATION
Ea. Amsterdam et al., LIMITATION OF MYOCARDIAL INFARCT SIZE IN PIGS WITH A DUAL LIPOXYGENASE-CYCLOOXYGENASE BLOCKING-AGENT BY INHIBITION OF NEUTROPHIL ACTIVITY WITHOUT REDUCTION OF NEUTROPHIL MIGRATION, Journal of the American College of Cardiology, 22(6), 1993, pp. 1738-1744
Objectives. The purpose of this study was to assess the effect of the
dual cyclooxygenase-lipoxygenase blocking agent BW755C on the extent o
f myocardial infarction in the pig and to identify the mechanisms of a
ny cardioprotective action of this drug. Background. Activated neutrop
hils contribute to reperfusion injury after myocardial infarction and
inhibition of neutrophil function can limit infarct size.Methods. In 9
control and 10 study pigs pretreated with intravenous BW755C (10 mg/k
g body weight) 30 min before coronary occlusion, ischemia was induced
by a 50-min occlusion of the mid left anterior descending coronary art
ery, followed by 3 h of reperfusion. Heart rate, arterial pressure, le
ft ventricular end diastolic pressure, the first derivative of left ve
ntricular pressure (dP/dt) and regional myocardial blood flow were mea
sured during control, occlusion and reperfusion periods. Infarct size
was determined by histochemical staining; and myeloperoxidase activity
, a marker for tissue neutrophil content, was assessed in normal and i
nfarcted myocardium. The effect of BW755C on the function of isolated
neutrophils stimulated with zymosan-activated serum was evaluated by m
easuring neutrophil degranulation, leukotriene B-4 production, superox
ide generation and chemotaxis. Results. Hemodynamic function and regio
nal myocardial blood Bow were similar in control and BW755C-treated an
imals. BW755C significantly reduced myocardial infarct size compared w
ith that in control animals, as measured by infarct/risk areas by hist
ochemical staining (39 +/- 5% vs. 63 +/- 7%, p < 0.05). Myocardial mye
loperoxidase activity was similar in normal, salvaged and infarcted ar
eas in the control and treated groups, indicating that neutrophil accu
mulation in injured myocardium was unaltered by BW755C. How ever, this
agent attenuated function of isolated, stimulated (zymosan-activated
serum) neutrophils. At a concentration of 0.03 mg/ml, BW755C inhibited
degranulation (-46%), leukotriene B-4 production (-48%) and superoxid
e generation (-74%), but there was minimal inhibition of chemotaxis in
vitro. Conclusions. These findings demonstrate that myocardial infarc
t size can be reduced by selective inhibition of neutrophil cytotoxic
activity without affecting neutrophil migration into injured myocardiu
m.